Hydrus microstent reduces IOP, medication burden

Posted on

The Hydrus microstent (Ivantis) combined with clear lensectomy reduces intraocular pressure (IOP) and restores aqueous outflow, according to data presented at the 2021 ASCRS Annual Meeting.

In this retrospective study, data from 186 eyes (baseline pre-operative vision better than 20/40) that underwent clear lensectomy combined with Hydrus stent implantation, were included. Six-month follow-up data was available for 105 eyes.

At baseline, for all study eyes, the average IOP was 14.67 ± 4.57 mmHg, the mean number of medications was 2.53 ± 1.47, and the average baseline visual field mean deviation was -8.36 dB.

For the 105 eyes who had 6 months follow-up, there was a reduction in mean IOP to 13.36 ± 2.92 mmHg. Mean medication count also decreased to 0.45 ±1.07.

Following the procedure, the proportion of patients not on any medications increased from 0% to 81%. The visual field improved from a mean of -8.37 dB to a mean of -8.17dB.

Laroche D, et al. Clear lensectomy and the Hydrus stent lower IOP and medication sse in Black and Afro-Latino patients with glaucoma. Presented at: 2021 ASCRS Annual Meeting.

Related Articles
IOP outcomes after laser trabeculoplasty in eyes with prior Kahook Dual Blade goniotomy limited
Jul 28, 2021
IOP, gel microstents complications leading cause of reoperation after MIGS
Jul 23, 2021
Are branched-chain amino acids associated with risk of POAG?
Jul 11, 2021